Clinical Trial Working Groups
|
 |
- Trial in start-up:
- ER+ and/or PR+ and HER2- breast cancer (Illinois)
- Approved LOI:
- AR+ triple negative breast cancer (Wisconsin)
- Current concepts:
- HER2+ breast cancer (Penn State)
- Triple negative breast cancer (Indiana)
- ER/PR+ breast cancer (Rutgers)
- Open trial:
- Esophageal (Indiana) - see also thoracic
- Trials in start-up:
- Approved LOI:
- Gastric/GE junction adenocarcinoma (Northwestern)
- Current concepts:
- Hepatocellular (Wisconsin)
- Colorectal (Wisconsin)
- Colorectal (Illinois)
- Pancreatic (Penn State)
- Pancreatic (Indiana)
- Open trial:
- Renal cell carcinoma (Illinois)
- Approved LOI:
- Current concepts:
- Kidney (Michigan)
- Urothelial (Indiana)
- Urothelial (Penn State)
- Prostate (Rutgers)
- Penile (Minnesota)
- Trial in start-up:
- Endometrial carcinoma (Northwestern)
- Current concept:
-
Current concepts
:
- Lymphoma (Minnesota)
- Peripheral T-cell lymphoma (Michigan) - 3 concepts
- Cutaneous T-cell lymphoma (Michigan) - 2 concepts
- Lymphoid/multiple myeloma (Indiana) - see also multiple myeloma
- Current concept:
- Squamous cell carcinoma of the skin (Rutgers)
- Current concept:
- Lymphoma/multiple myeloma (Indiana) - see also lymphoid
- Current concepts:
- AML (Illinois)
- AML (Indiana)
- MDS (Penn State)
- Open trial:
-
Esophageal (Indiana) -
see also gastrointestinal
- Approved LOI:
- NSCLC (Illinois)
- NCSLC (Indiana)
- Current concepts:
- Splice variants in lung cancer in women (Illinois)
- HER2 expression and targeted therapy (Illinois)
- Non-small cell lung cancer (Illinois)
- Small cell lung cancer (Illinois)
- Squamous cell lung cancer (Nebraska)
- Adenoid cystic carcinoma (Nebraska)
To Discuss Protocols: Contact Jessica Roy at
[email protected] or 317-634-5842, ext. 19
To Join a CTWG or Submit an LOI: Contact Anita Borek at
|
|
|
|
The Big Ten Cancer Research Consortium will host meetings for the BTCRC Foundation, Cancer Center Directors, Steering Committee, and Clinical Trial Working Groups during ASCO 2016.
Meetings will be at the Holiday Inn Chicago Mart Plaza River North, 350 West Mart Center Drive, Chicago, Ill.
All Clinical Trial Working Groups will hold meetings. Contact Anita Borek at [email protected] with questions.
Visit the BTCRC at Booth # 25099 at McCormick Place South, Exhibit Hall A. See booth location.
|
|
Goodin presents at Indiana Cancer Consortium Meeting
|
Big Ten Cancer Research Consortium Executive Officer
Susan Goodin, PharmD, recently presented at the Annual Meeting of the Indiana Cancer Consortium. Dr. Goodin stressed the importance of research in advancing cancer treatments and survivorship.
|
|
Benson elected president of NPAF executive board
|
Al B. Benson III, MD, associate director for cooperative groups at the
Robert H. Lurie Comprehensive Cancer Center of Northwestern University, was elected president of the National Patient Advocate Foundation (NPAF) Executive Board. An esteemed oncologist and professor of medicine in the Division of Hematology/Oncology at the Feinberg School of Medicine, Dr. Benson brings insights into the issues and roadblocks patients face as they navigate the healthcare system to this role.
Dr. Benson is a member of the BTCRC steering committee, representing the Robert H. Lurie Comprehensive Cancer Center of Northwestern University. He is also a co-chair of the BTCRC's
Gastrointestinal Clinical Trial Working Group
.
Read more.
|
 Big Ten cancer centers continue to make gains in cancer research and treatment. In this edition of
Across the Consortium, we highlight research from our member institutions in prostate, neuroendocrine, blood, pancreatic, and other cancers; we celebrate with the University of Iowa Holden Comprehensive Cancer Center upon its receiving a SPORE grant for new research projects on neuroendocrine tumors; we congratulate those strategically entering into new roles within the cancer research community; and we root for members advancing in cancer prevention programs.
Read more
.
Want more news from
Across the Consortium?
|
|
Cancer Awareness Series
Celebrating survivorship
|
As Big Ten Cancer Research Consortium members work every day to defeat cancer, they are constantly aware that behind every office appointment, pathology report, and scan is the story of a survivor. In honor of National Cancer Survivors Day on June 5, we celebrate examples of our members working to improve the lives of all patients with cancer. Read more.
Taking aim at skin cancer
The diagnosis of a rare and highly aggressive type of skin cancer anywhere on the body is frightening enough, but when it is found inside the nose, the road to a cure can look ghastly. A new team in head, neck and skull-based surgery at Rutgers Cancer Institute of New Jersey is helping to take away this fear. For Tony Spadora, that meant the right hands at the right time.
|
|
|
